ID

26665

Descrizione

Study ID: 100690 Clinical Study ID: NKP100690 Study Title: A randomised, double blind triple dummy, placebo controlled balanced incomplete block crossover study to evaluate the change in response to a 7% CO2 challenge and pharmacokinetics of single oral doses of GW597599 and paroxetine (5 or 7.5 mg) either alone or in combination, or alprazolam (0.75 mg) in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: paroxetine Trade Name: Tagonis,Seroxat,Paxil,Paroxat,Deroxat,Aropax Study Indication: Depressive Disorder and Anxiety Disorders CRF Seiten: 255-365

Keywords

versioni (1)
  1. 23/10/17 23/10/17 -
Titolare del copyright

GSK

Caricato su

23 ottobre 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

7% CO2, GW597599, paroxetine andor alprazolam in healthy volunteers 100690

Inglese

Adverse Event

1 moduli  
  1. StudyEvent: ODM
    1. Adverse Event
Please note any SERIOUS events should not be recorded on this page, but on the Serious Adverse Event pages provided. Record any Adverse event (using standard medical terminology) observed or elicited by the following direct question to the subject: "Do you feel different in any way since starting the treatment or since the last visit?" Provide the diagnosis not symptoms where possible. (One adverse event per column) If no adverse events, please mark box D and sign form below
Descrizione

Please note any SERIOUS events should not be recorded on this page, but on the Serious Adverse Event pages provided. Record any Adverse event (using standard medical terminology) observed or elicited by the following direct question to the subject: "Do you feel different in any way since starting the treatment or since the last visit?" Provide the diagnosis not symptoms where possible. (One adverse event per column) If no adverse events, please mark box D and sign form below

Alias
UMLS CUI-1
C0877248
Adverse Event
Descrizione

Adverse Event

Tipo di dati

text

Alias
UMLS CUI [1]
C0877248
GSK Use
Descrizione

Investigator Use

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0008961
UMLS CUI [1,2]
C0457083
Onset Date/Time
Descrizione

Onset Date/Time

Tipo di dati

datetime

Alias
UMLS CUI [1]
C2826806
End Date/Time
Descrizione

End Date/Time

Tipo di dati

datetime

Alias
UMLS CUI [1]
C2826793
Outcome
Descrizione

Outcome

Tipo di dati

text

Alias
UMLS CUI [1]
C1705586
Event Course
Descrizione

Event Course

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0750729
Intensity (Maximum)
Descrizione

Intensity

Tipo di dati

text

Alias
UMLS CUI [1]
C1710066
Action Taken with Respect to lnvestigational Drug
Descrizione

Drug Action Taken

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2826626
UMLS CUI [1,2]
C0304229
Relationship to lnvestigational Drug
Descrizione

Relationship to lnvestigational Drug

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0439849
UMLS CUI [1,3]
C0304229
Corrective Therapy. If "Yes", Please record on Concomitant Medication form
Descrizione

Corrective Therapy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0087111
Was subject withdrawn due to this AE?
Descrizione

Study withdrawal

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0877248
Administrative Documentation
Descrizione

Administrative Documentation

Alias
UMLS CUI-1
C1320722
Subject Number
Descrizione

Subject Number

Tipo di dati

text

Alias
UMLS CUI [1]
C2348585
Investigator's Signature:
Descrizione

Investigators Signature

Tipo di dati

text

Alias
UMLS CUI [1]
C2346576
Date
Descrizione

Investigator Signature Date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0807937
UMLS CUI [1,2]
C2346576
Ritorna all'inizio della pagina

Similar models

Adverse Event

1 moduli
  1. StudyEvent: ODM
    1. Adverse Event
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Please note any SERIOUS events should not be recorded on this page, but on the Serious Adverse Event pages provided. Record any Adverse event (using standard medical terminology) observed or elicited by the following direct question to the subject: "Do you feel different in any way since starting the treatment or since the last visit?" Provide the diagnosis not symptoms where possible. (One adverse event per column) If no adverse events, please mark box D and sign form below
C0877248 (UMLS CUI-1)
Adverse Event
Item
Adverse Event
text
C0877248 (UMLS CUI [1])
Investigator Use
Item
GSK Use
text
C0008961 (UMLS CUI [1,1])
C0457083 (UMLS CUI [1,2])
Onset Date/Time
Item
Onset Date/Time
datetime
C2826806 (UMLS CUI [1])
End Date/Time
Item
End Date/Time
datetime
C2826793 (UMLS CUI [1])
Item
Outcome
text
C1705586 (UMLS CUI [1])
Outcome
Code List
Outcome
CL Item
Resolved (Resolved)
CL Item
Ongoing (Ongoing)
Item
Event Course
text
C0877248 (UMLS CUI [1,1])
C0750729 (UMLS CUI [1,2])
Event Course
Code List
Event Course
CL Item
Intermittent (Number of Episodes) (Intermittent (Number of Episodes))
CL Item
Constant (Constant)
Item
Intensity (Maximum)
text
C1710066 (UMLS CUI [1])
Intensity
Code List
Intensity (Maximum)
CL Item
Mild (Mild)
CL Item
Moderate (Moderate)
CL Item
Severe (Severe)
Item
Action Taken with Respect to lnvestigational Drug
text
C2826626 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Drug Action Taken
Code List
Action Taken with Respect to lnvestigational Drug
CL Item
None (None)
CL Item
Dose Reduced (Dose Reduced)
CL Item
Dose increased (Dose increased)
CL Item
Dose interrupted/restarted (Dose interrupted/restarted)
CL Item
Drug stopped (Drug stopped)
Item
Relationship to lnvestigational Drug
text
C0877248 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
Relationship to lnvestigational Drug
Code List
Relationship to lnvestigational Drug
CL Item
Not related (Not related)
CL Item
Unlikely (Unlikely)
CL Item
Suspected (Reasonable possibility) (Suspected (Reasonable possibility))
CL Item
Probable (Probable)
Corrective Therapy
Item
Corrective Therapy. If "Yes", Please record on Concomitant Medication form
boolean
C0877248 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Study withdrawal
Item
Was subject withdrawn due to this AE?
boolean
C0422727 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
Item Group
C1320722 (UMLS CUI-1)
Subject Number
Item
Subject Number
text
C2348585 (UMLS CUI [1])
Investigators Signature
Item
Investigator's Signature:
text
C2346576 (UMLS CUI [1])
Investigator Signature Date
Item
Date
date
C0807937 (UMLS CUI [1,1])
C2346576 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial